A 3-in-1 Natural GLP-1 Alternative Gaining National Attention for Combating Insulin Resistance, Cravings, and Metabolic ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

The Trump Administration is reportedly mulling over a policy to match U.S. drug prices with those in other developed nations.

Corcept sees 40% growth in 2025 revenue with promising trials, expanded patient base, and strong projections. Read my ...

Drugmakers have been warned that the Trump Administration is considering linking U.S. medicine prices to lower amounts paid ...

Westbury’s school district is continuing its tradition of leveraging lawsuits to advocate for the school’s community.

President Trump signed an executive order (EO) with the aim of reducing the cost of prescription drugs. Although the EO is ...